Dr. Muhammad Wasim: Postdoctoral Fellow at Maternal and Children’s Health Research Institute, Shunde Women and Children’s Hospital, Guangdong Medical University, China
-
Name: Dr. Muhammad Wasim
- Current Role/Designation: Postdoctoral Fellow
-
Organization/Institution Details: Maternal and Children’s Health Research Institute, Shunde Women and Children’s Hospital, Guangdong Medical University, Foshan, 528300, China
-
Country: China
-
Subject Track: Neuroscience
- Award Categories: Best Innovator Award
Dr. Muhammad Wasim is a passionate neuroscientist and experienced postdoctoral researcher currently working at the Maternal and Children’s Health Research Institute, Shunde Women and Children’s Hospital, Guangdong Medical University, China. With a strong foundation in molecular neuroscience, his academic and research interests lie at the intersection of brain and systemic diseases, particularly focusing on neurological and respiratory disorders. He has consistently contributed to translational neuroscience through impactful publications, exploring mechanisms behind epilepsy, Alzheimer’s disease, depression, and rare genetic disorders. Dr. Wasim brings a multidisciplinary approach to his work, combining molecular biology, behavioral studies, and clinical collaboration to address complex biomedical questions.
Online Profiles
As of 2025, Dr. Muhammad Wasim has accumulated a total of 560 citations across his body of published work, with 450 citations since 2020, demonstrating the growing relevance of his research in recent years. He holds an h-index of 9, indicating that at least nine of his publications have been cited nine times or more, and an i10-index of 9, reflecting nine papers with at least ten citations each. These metrics underscore the academic impact and citation strength of his contributions to neuroscience, epilepsy, neurodegeneration, and translational medicine.
Education
Dr. Wasim earned his PhD in Neuroscience from the National Institute for Biotechnology and Genetic Engineering (NIBGE), affiliated with the Pakistan Institute of Engineering and Applied Sciences (PIEAS), one of the country’s premier scientific research institutions. He completed his doctoral degree on 21 September 2020, where his thesis work was focused on exploring molecular and epigenetic factors contributing to Alzheimer’s disease. His academic training included extensive work in gene expression analysis, neurobehavioral studies, and the evaluation of bioactive compounds for therapeutic applications. His strong academic background has equipped him with both theoretical knowledge and hands-on laboratory expertise in neuroscience.
Research Focus
Dr. Wasim’s current research at Guangdong Medical University explores the relationship between respiratory diseases and neurological impairment, especially in maternal and pediatric populations. Previously, his work at Aga Khan University delved into temporal lobe epilepsy and neurodegeneration, investigating hippocampal sclerosis and seizure pathology. Across his career, he has maintained a strong interest in the therapeutic potential of natural products, miRNA regulation, and neuroinflammation. He continues to pursue research that bridges basic neuroscience with clinical relevance, particularly targeting neurodevelopmental disorders, Alzheimer’s disease, anxiety, and depression models using multi-omics and behavioral methodologies.
Experience
Dr. Wasim’s research journey spans over a decade, beginning with his PhD in Pakistan and extending into international postdoctoral roles. His first postdoctoral fellowship at Aga Khan University focused on clinical and experimental epilepsy research, where he worked with both patient data and animal models. Currently, as a postdoctoral fellow in China, he is involved in cutting-edge research examining the molecular links between respiratory health and brain function in children and mothers. He has collaborated with multidisciplinary teams across Pakistan, Denmark, and China, and has contributed to mentoring junior researchers, conducting grant writing, and managing multi-lab projects involving in vivo experimentation and omics data analysis.
Research Timeline & Activities
Since 2020, Dr. Wasim has actively contributed to neuroscience research through experimental design, data interpretation, and cross-border collaborations. His timeline includes involvement in multiple projects such as proteomic profiling in intellectual disability, molecular docking in phytopharmacology, and translational studies in genetic disorders. He regularly engages in conference presentations, scientific writing, peer reviewing, and supervising lab activities. His contributions span from rodent model development and behavioral testing to neurochemical analysis and bioinformatics, reflecting his well-rounded profile as a modern biomedical researcher. His work demonstrates a commitment to interdisciplinary science, clinical translation, and the training of the next generation of neuroscientists.
Awards & Honors
Dr. Wasim has been the recipient of several academic distinctions and research fellowships, reflecting his high-impact contributions in the field of neuroscience. During his PhD, he was supported by competitive government-funded research scholarships, and he has since received international recognition through postdoctoral appointments in Pakistan and China. He has also been awarded travel grants to attend scientific conferences and has received commendations for his work on epilepsy and Alzheimer’s disease. His dedication to research excellence has been acknowledged through collaborations with leading institutions and consistent publication in high-ranking peer-reviewed journals.
Top Noted Publication
Among Dr. Wasim’s numerous publications, one of his most impactful works is the 2025 article titled “miR-137: A therapeutic candidate or a key molecular regulator in Alzheimer’s disease?”, published in the Journal of Alzheimer’s Disease Reports. This paper highlights the emerging role of microRNA-137 in regulating neurodegeneration, synaptic plasticity, and cognitive dysfunction, positioning it as a potential therapeutic target in Alzheimer’s therapy. The study integrates molecular biology, clinical insight, and bioinformatics approaches, making it a highly referenced and influential publication in the field of neurodegenerative research.
-
miR-137: A therapeutic candidate or a key molecular regulator in Alzheimer’s disease?
M. Wasim, J. Guo, Z. Wang, R. Parveen, R. Chen, Y. Wang, G. Ma
Journal of Alzheimer’s Disease Reports, 9, 25424823251352166 (2025). -
Phenotypic and Genotypic Landscape of Epileptic Encephalopathies in Children with Seven Novel Variants: A Single Tertiary Care Hospital Experience
I. Javed, H.N. Khan, T. Sultan, M. Wasim
Neurochemical Journal, 19(2), 217-226 (2025). -
Exploring Proteomic Alterations in Intellectual Disability: Insights from Hyperlipidemia and Hyperphosphatasia Subgroups
S. Vankwani, M.R. Mirza, M. Tahir, M. Wasim, S.A. Rajput, H.N. Khan, et al.
NeuroMolecular Medicine, 27(1), 38 (2025). -
Neuroprotective Role of Epigallocatechin-3-Gallate, Albeginin and Melanoxetin in Alzheimer’s Disease
A. Malik, M. Hassan, S. Waquar, M. Wasim, A. Naz, F.M. Awan, M.T. Khan, et al.
Phytomedicine Plus, 5(1), 100740 (2025). -
Antidepressive and Anxiolytic Effects of a Combination of Saffron and Chamomile in Rats and Their Relationship with Serotonin Using In Vivo Methods
A. Faiq, A. Saara, W. Muhammad, K. Asra, M.A. Fazal, B. Zehra, T. Saiqa, et al.
Journal of Traditional Chinese Medicine, 45(1), 49 (2025).